Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Teriflunomide

A list of these Teriflunomide articles makes it easy for you to quickly access relevant information. We have prepared the following professional Teriflunomide, hoping to help solve your questions and better understand the product information you care about.
  • Drug Patent & Exclusivity Expiration Report - Week of Oct 28 2024

    Drug Patent & Exclusivity Expiration Report - Week of Oct 28 2024

    2024-10-28

    This week, there are 6 drugs in the patent and exclusivity list. They are: - ALEXZA PHARMACEUTICALS INC's ADASUVE, containing active ingredient LOXAPINE - ASTRAZENECA PHARMACEUTICALS LP's BRILINTA, containing active ingredient TICAGRELOR - CORMEDIX INC's DEFENCATH, containing active ingredient HEPARIN SODIUM; TAUROLIDINE - ABBVIE INC's VUITY, containing active ingredient PILOCARPINE HYDROCHLORIDE - SANOFI AVENTIS US LLC's AUBAGIO, containing active ingredient TERIFLUNOMIDE - ASTRAZENECA UK LTD's CALQUENCE, containing active ingredient ACALABRUTINIB Read More